THOROFARE, N.J., Aug. 24, 2021 /PRNewswire/ -- Healio is expanding its ever-growing specialty news content with the launch of Allergy and Asthma and Women's Health & OB/GYN. Coverage will include late-breaking reports from national and international congresses, as well as treatment and diagnostic updates, FDA developments, clinical resources and guidelines for care.
"These launches are an extension of the continued growth Healio has experienced over the past year, identifying a need that these health care professionals have for a fresh voice in news," said Joan-Marie Stiglich, ELS, Healio's Chief Content Officer. "We look forward to helping these communities keep up with the latest advances as well as providing additional perspective to the current knowledge."
Healio relaunched In June 2020, bringing health care professionals an enhanced user experience that provides highly personalized news and education tailored to fit their daily practice of medicine.
For advertisers, this launch presents unique opportunities to reach the U.S. universe of practitioners in Allergy, Asthma, Women's Health and OB/GYN through innovative advertising and custom solutions. For more information, contact Matthew J. Holland, Chief Commercial Officer, at [email protected] or 973-580-8595.
About Healio
Healio is a multichannel information platform, providing health care specialists with tailored news, information and education in support of their daily practice of medicine. An in-depth, clinical information resource, Healio brings together award-winning news reporting with expert perspectives, dynamic video, podcasts, question-and-answer columns, CME and other custom educational activities, blogs, peer-reviewed journals and a wide range of popular medical book titles all in one place. For more information, visit Healio.com.
CONTACT:
Healio
Lee Gaymon
SVP, Marketing
[email protected]
856-994-9900 ext. 356
SOURCE Healio
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article